Lynx Investment Advisory Viatris Inc Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in Viatris Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 421 shares of VTRS stock, worth $4,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
421Holding current value
$4,976% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.66 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.1 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$734 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$680 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$672 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...